VivoSim Labs, INC. (VIVS) stock
VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.12−0.00 (-0.08%)
Close on Nov 18, 2026Market cap $383.32KP/E –Yield –
VivoSim Labs price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
VivoSim Labs's price to sales ratio was 4.4× on Nov 11, 2026, against 41.7× a year earlier. Over the last 5 years it ranged from 4.4× to 288.9×, with a median of 27.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.4× | −29.3 |
| 2025 | Dec 31, 2025 | 33.7× | −34.9 |
| 2024 | Dec 31, 2024 | 68.6× | +42.3 |
| 2023 | Dec 29, 2023 | 26.3× | +18.5 |
| 2022 | Dec 30, 2022 | 7.8× | −281.2 |
| 2021 | Jan 29, 2021 | 288.9× | +11.1 |
| 2020 | Dec 31, 2020 | 277.9× | +263.9 |
| 2019 | Dec 31, 2019 | 14.0× | −14.4 |
| 2018 | Dec 31, 2018 | 28.4× | −4.8 |
| 2017 | Dec 29, 2017 | 33.3× | −67.9 |
| 2016 | Dec 30, 2016 | 101.1× | −122.3 |
| 2015 | Dec 31, 2015 | 223.4× | −263.6 |
| 2014 | Dec 31, 2014 | 487.0× | +52.8 |
| 2013 | Nov 29, 2013 | 434.3× | +374.0 |
| 2012 | Dec 31, 2012 | 60.2× | – |
See a number that looks wrong?